Literature DB >> 29655180

An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital.

Alba Ruiz-Gaitán1, Ana M Moret2, María Tasias-Pitarch3, Ana I Aleixandre-López2, Héctor Martínez-Morel4, Eva Calabuig4, Miguel Salavert-Lletí3, Paula Ramírez1,5, José L López-Hontangas6, Ferry Hagen7,8, Jacques F Meis7,9, Juan Mollar-Maseres3, Javier Pemán1,6.   

Abstract

Multidrug-resistant Candida auris has emerged as a cause of insidious hospital outbreaks and complicated infections. We present the analysis of an ongoing C. auris outbreak including the largest published series of C. auris bloodstream infection. All C. auris-positive patients from April-2016 to January-2017 were included. Environmental, clinical and microbiological data were recorded. Definitive isolate identification was performed by ITS-rDNA sequencing, and typing by amplified fragment length polymorphism fingerprinting. One hundred and forty patients were colonised by C. auris during the studied period (68% from surgical intensive care). Although control measures were implemented, we were not able to control the outbreak. Forty-one invasive bloodstream infections (87.8% from surgical intensive care) were included. Clinical management included prompt intravascular catheter removal and antifungal therapy with echinocandins. All isolates were fluconazole- and voriconazole-resistant, but echinocandin- and amphotericin B-susceptible. Thirty-day mortality rate was 41.4%, and severe septic metastasis as spondylodiscitis and endocarditis were observed in 5 patients (12%). C. auris was also recovered from inanimate patient surroundings and medical equipment. Despite antifungal treatment, high mortality and late complication rates were recorded. Molecular typing suggested a clonal outbreak different from those previously published.
© 2018 Blackwell Verlag GmbH.

Entities:  

Keywords:  zzm321990Candida auriszzm321990; candidaemia; colonisation; genotyping; healthcare-associated infections; outbreak

Mesh:

Substances:

Year:  2018        PMID: 29655180     DOI: 10.1111/myc.12781

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  87 in total

1.  Insights into the Unique Nature of the East Asian Clade of the Emerging Pathogenic Yeast Candida auris.

Authors:  Rory M Welsh; D Joseph Sexton; Kaitlin Forsberg; Snigdha Vallabhaneni; Anastasia Litvintseva
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

2.  Invasive Candida auris infections in Kuwait hospitals: epidemiology, antifungal treatment and outcome.

Authors:  Ziauddin Khan; Suhail Ahmad; Khalifa Benwan; Prashant Purohit; Inaam Al-Obaid; Ritu Bafna; Maha Emara; Eiman Mokaddas; Aneesa Ahmed Abdullah; Khaled Al-Obaid; Leena Joseph
Journal:  Infection       Date:  2018-06-14       Impact factor: 3.553

Review 3.  Candida auris: a fungus with identity crisis.

Authors:  Taissa Vila; Ahmed S Sultan; Daniel Montelongo-Jauregui; Mary Ann Jabra-Rizk
Journal:  Pathog Dis       Date:  2020-06-01       Impact factor: 3.166

4.  Experimental Evolution Identifies Adaptive Aneuploidy as a Mechanism of Fluconazole Resistance in Candida auris.

Authors:  Jian Bing; Tianren Hu; Qiushi Zheng; José F Muñoz; Christina A Cuomo; Guanghua Huang
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

5.  Impact of Candida auris Infection in a Neutropenic Murine Model.

Authors:  Steven R Torres; Amber Pichowicz; Fernando Torres-Velez; Renjie Song; Navjot Singh; Erica Lasek-Nesselquist; Magdia De Jesus
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

6.  In Vitro Evaluation of Antifungal Drug Combinations against Multidrug-Resistant Candida auris Isolates from New York Outbreak.

Authors:  Brittany O'Brien; Sudha Chaturvedi; Vishnu Chaturvedi
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

7.  Development and Characterization of Monoolein-Based Liposomes of Carvacrol, Cinnamaldehyde, Citral, or Thymol with Anti-Candida Activities.

Authors:  Katherine Miranda-Cadena; Marisol Dias; Augusto Costa-Barbosa; Tony Collins; Cristina Marcos-Arias; Elena Eraso; Célia Pais; Guillermo Quindós; Paula Sampaio
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

8.  Novel ERG11 and TAC1b mutations associated with azole resistance in Candida auris.

Authors:  Jizhou Li; Alix T Coste; Maroussia Liechti; Daniel Bachmann; Dominique Sanglard; Frederic Lamoth
Journal:  Antimicrob Agents Chemother       Date:  2021-02-22       Impact factor: 5.191

9.  Efficacy of Voriconazole, Isavuconazole, Fluconazole, and Anidulafungin in the Treatment of Emerging Candida auris Using an Immunocompromised Murine Model of Disseminated Candidiasis.

Authors:  Ahmed Gamal; Lisa Long; Janet Herrada; Jalal Aram; Thomas S McCormick; Mahmoud A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

10.  Murine model of colonization with fungal pathogen Candida auris to explore skin tropism, host risk factors and therapeutic strategies.

Authors:  Xin Huang; Charlotte Hurabielle; Rebecca A Drummond; Nicolas Bouladoux; Jigar V Desai; Choon K Sim; Yasmine Belkaid; Michail S Lionakis; Julia A Segre
Journal:  Cell Host Microbe       Date:  2020-12-31       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.